Cargando…
Cumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney Transplantation
T-cell depleting antibody is associated with an increased risk of cancer after kidney transplantation, but a dose-dependent relationship has not been established. This study aimed to determine the association between cumulative doses of T-cell depleting antibody and the risk of cancer after kidney t...
Autores principales: | Chen, Jenny H. C., Wong, Germaine, Chapman, Jeremy R., Lim, Wai H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640502/ https://www.ncbi.nlm.nih.gov/pubmed/26555791 http://dx.doi.org/10.1371/journal.pone.0139479 |
Ejemplares similares
-
Recurrent and de novo Glomerulonephritis After Kidney Transplantation
por: Lim, Wai H., et al.
Publicado: (2019) -
Prior cancer history and suitability for kidney transplantation
por: Wong, Germaine, et al.
Publicado: (2023) -
Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?
por: Lim, Wai H., et al.
Publicado: (2019) -
Donors With a Prior History of Cancer: Factors of Non-Utilization of Kidneys for Transplantation
por: Lim, Wai H., et al.
Publicado: (2023) -
Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer – a population cohort study
por: Lim, Wai H., et al.
Publicado: (2017)